Cancer BiologybioRxivPreprint
Discovery and characterization of FX-909, a covalent inverse agonist of PPARG rationally designed to impose a powerful repressive bias in PPARG for the treatment of PPARG/RXRA-activated muscle-invasive urothelial cancers
Jacob I. Stuckey, Jennifer A. Mertz, Jonathan E. Wilson…·Robert J. Sims
3 citations